Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

AUPHAurinia Pharmaceuticals Inc.

Nasdaq · CIK 0001600620
Filer categoryLarge accelerated filer
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts452

Identity from submissions API

NameAurinia Pharmaceuticals Inc.
CIK0001600620
TickersAUPH
ExchangesNasdaq
Entity typeoperating
CategoryLarge accelerated filer
SIC2834 Pharmaceutical Preparations
EIN981231763
LEI—
Fiscal year end1231
State of incorporation—
Phone250-744-2487
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
#140, 14315 - 118 AVENUE
EDMONTON
A0
T5L 4S6
Alberta, Canada
Mailing address
#140, 14315 - 118 AVENUE
EDMONTON
A0
T5L 4S6
Alberta, Canada

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

616 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 4 FORM 4 0001600620-26-000077 5475
2026-10-30 10-Q 10-Q 0001600620-26-000075 001-36421 261504490 34 5476436 1 1
2026-10-30 8-K 8-K 2.02,9.01 0001600620-26-000074 001-36421 261504486 34 344106 1 1
2026-09-11 4 FORM 4 0001600620-26-000068 5475
2026-08-26 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001104659-26-101785 005-88628 261324777 34 27122
2026-08-25 4 FORM 4 0001837798-26-000013 5700
2026-08-21 144 xsl144X01/primary_doc.xml 0001837798-26-000010 001-36421 261306204 33 4751
2026-08-19 8-K 8-K 8.01 0001600620-26-000066 001-36421 261295318 34 177107 1 1
2026-08-06 10-Q 10-Q 0001600620-26-000062 001-36421 261246200 34 5568882 1 1
2026-08-06 8-K 8-K 2.02,9.01 0001600620-26-000059 001-36421 261246122 34 341097 1 1
2026-06-08 4 FORM 4 0001370348-26-000002 5415
2026-06-08 4 FORM 4 0001896369-26-000002 5316
2026-06-08 4 FORM 4 0001302605-26-000002 5538
2026-06-08 4 FORM 4 0001500210-26-000002 5390
2026-06-05 144 xsl144X01/primary_doc.xml 0001950047-26-005702 001-36421 261069508 33 6004
2026-06-04 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001214659-26-007175 005-88628 261066390 34 28929
2026-06-04 8-K 8-K 5.07,9.01 0001600620-26-000053 001-36421 261065228 34 172576 1 1
2026-06-04 144 xsl144X01/primary_doc.xml 0001950047-26-005622 001-36421 261065087 33 5306
2026-06-02 4 xslF345X06/form4-06032026_010631.xml 0001178579-26-000004 17196
2026-06-02 144 xsl144X01/primary_doc.xml 0001950047-26-005481 001-36421 261056145 33 4597
2026-05-20 4 FORM 4 0001837798-26-000005 5149
2026-05-20 4 FORM 4 0001759910-26-000004 7495
2026-05-20 4 FORM 4 0002126966-26-000003 7476
2026-05-11 144 xsl144X01/primary_doc.xml 0001950047-26-004312 001-36421 26963322 33 4878
2026-05-11 144 xsl144X01/primary_doc.xml 0001950047-26-004310 001-36421 26963270 33 4897
2026-05-11 144 xsl144X01/primary_doc.xml 0001950047-26-004306 001-36421 26963208 33 4871
2026-05-11 8-K 8-K 2.01,9.01 0001140361-26-020402 001-36421 26961165 34 171717 1 1
2026-05-11 SC TO-T/A SC TO-T/A 0001140361-26-020397 213307
2026-05-07 10-Q 10-Q 0001600620-26-000049 001-36421 26951017 34 5560928 1 1
2026-05-07 8-K 8-K 2.02,9.01 0001600620-26-000048 001-36421 26951014 34 314358 1 1
2026-04-21 DEF 14A DEF 14A 0001600620-26-000039 001-36421 26879945 34 3888916 1 1
2026-04-13 SC TO-T SC TO-T 0001140361-26-014344 9664633 1 1
2026-04-03 8-K 8-K 1.01,7.01,9.01 0001600620-26-000035 001-36421 26838798 34 49443493 1 1
2026-04-02 3 FORM 3 0001600620-26-000030 14813
2026-04-02 3 FORM 3 0001600620-26-000029 14874
2026-03-25 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001214659-26-003784 005-88628 26792606 34 12717
2026-03-23 8-K 8-K 5.02,9.01 0001600620-26-000026 001-36421 26779950 34 181451 1 1
2026-03-10 4 FORM 4 0001600620-26-000024 4615
2026-03-03 4 xslF345X05/form4-03032026_100309.xml 0001178579-26-000001 13915
2026-03-03 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001214659-26-002769 005-88628 26716882 34 26103
2026-03-03 4 FORM 4 0001600620-26-000023 8672
2026-03-03 4 FORM 4 0001600620-26-000022 8691
2026-03-03 4 FORM 4 0001600620-26-000021 8680
2026-03-03 4 FORM 4 0001600620-26-000020 7019
2026-03-03 4 FORM 4 0001600620-26-000019 8638
2026-02-26 10-K 10-K 0001600620-26-000017 001-36421 26681466 34 14700671 1 1
2026-02-26 8-K 8-K 2.02 0001600620-26-000015 001-36421 26681454 34 357011 1 1
2026-02-23 4 FORM 4 0001636642-26-000002 4734
2026-02-23 4 FORM 4 0001363683-26-000002 4718
2026-02-23 4 FORM 4 0001746372-26-000002 4715
2026-02-23 4 FORM 4 0001837798-26-000002 4681
2026-02-03 4 FORM 4 0002044006-26-000002 4616
2026-01-05 4 FORM 4 0001600620-26-000005 6663
2026-01-05 4 FORM 4 0001600620-26-000004 6720
2026-01-05 4 FORM 4 0001600620-26-000003 6701
2026-01-05 4 FORM 4 0001600620-26-000002 6706
2025-11-24 4 FORM 4 0001600620-25-000110 4623
2025-11-24 4 FORM 4 0001370348-25-000004 4648
2025-11-04 8-K 8-K 2.02 0001600620-25-000108 001-36421 251446508 34 4381213 1 1
2025-11-04 10-Q 10-Q 0001600620-25-000106 001-36421 251446246 34 5305848 1 1
2025-08-13 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001104659-25-077809 005-88628 251213875 34 28906
2025-08-05 4 xslF345X05/form4-08052025_090800.xml 0001415889-25-021066 8848
2025-08-05 4 FORM 4 0001600620-25-000095 4910
2025-07-31 10-Q 10-Q 0001600620-25-000092 001-36421 251169168 34 5310489 1 1
2025-07-31 8-K 8-K 2.02,8.01,9.01 0001600620-25-000090 001-36421 251169115 34 338472 1 1
2025-06-30 8-K 8-K 8.01 0001600620-25-000083 001-36421 251088641 34 2606244 1 1
2025-05-16 4 FORM 4 0001600620-25-000078 5364
2025-05-16 4 FORM 4 0001600620-25-000077 5133
2025-05-16 4 FORM 4 0001600620-25-000076 5102
2025-05-16 4 FORM 4 0001600620-25-000075 5176
2025-05-16 3 FORM 3 0001600620-25-000074 3244
2025-05-16 3 FORM 3 0001600620-25-000073 2982
2025-05-16 S-8 S-8 0001600620-25-000072 333-287371 25960323 33 555156 1 1
2025-05-15 8-K 8-K 5.02,5.03,5.07 0001600620-25-000057 001-36421 25952765 34 15085421 1 1
2025-05-12 10-Q 10-Q 0001600620-25-000049 001-36421 25932430 34 4922914 1 1
2025-05-12 8-K 8-K 2.02 0001600620-25-000047 001-36421 25932377 34 322976 1 1
2025-04-30 DEFA14A DEFA14A 0001600620-25-000040 001-36421 25890639 34 258078
2025-04-29 DEFA14A DEFA14A 0001600620-25-000036 001-36421 25882467 34 239727
2025-04-17 DEF 14A DEF 14A 0001600620-25-000032 001-36421 25847216 34 3844654 1 1
2025-03-07 4 FORM 4 0001600620-25-000026 5172
2025-03-04 4 FORM 4 0001600620-25-000024 13230
2025-03-04 4 FORM 4 0001600620-25-000022 9169
2025-03-04 4 FORM 4 0001600620-25-000020 13266
2025-03-04 4 FORM 4 0001600620-25-000019 13240
2025-03-04 4 FORM 4 0001600620-25-000018 13293
2025-03-04 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001214659-25-003856 005-88628 25706009 34 35780
2025-03-04 4 xslF345X05/form4-03042025_100358.xml 0001415889-25-006589 14160
2025-02-27 10-K 10-K 0001600620-25-000011 001-36421 25672622 34 11941576 1 1
2025-02-27 8-K 8-K 2.02 0001600620-25-000009 001-36421 25672592 34 350968 1 1
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-001245 005-88628 25630657 34 10680
2024-12-09 4 xslF345X05/form4-12092024_091246.xml 0001415889-24-028661 8980
2024-11-25 4 FORM 4 0001600620-24-000126 6781
2024-11-25 4 FORM 4 0001600620-24-000124 6729
2024-11-25 4 FORM 4 0001600620-24-000122 6754
2024-11-25 4 FORM 4 0001600620-24-000120 6797
2024-11-25 4 FORM 4 0001600620-24-000118 6743
2024-11-14 SC 13G/A armistice-auph093024a1.htm 0001172661-24-005289 005-88628 241463685 34 90516
2024-11-12 4 FORM 4 0001600620-24-000116 8766
2024-11-12 4 FORM 4 0001600620-24-000114 8750
2024-11-12 3 FORM 3 0001600620-24-000112 5148
2024-11-12 3 FORM 3 0001600620-24-000110 2984
2024-11-07 10-Q 10-Q 0001600620-24-000108 001-36421 241432960 34 6236438 1 1
2024-11-07 8-K 8-K 2.02,2.05,5.02,9.01 0001600620-24-000106 001-36421 241432939 34 372809 1 1
2024-09-23 3 xslF345X02/form3-09232024_080915.xml 0001415889-24-023834 5775
2024-09-20 4 xslF345X05/form4.xml 0000912282-24-000666 2794
2024-09-12 SC 13D e910242sc13d.htm 0001214659-24-016381 005-88628 241295043 34 158892
2024-09-12 8-K 8-K 5.02,5.03,7.01,9.01 0001600620-24-000099 001-36421 241295014 34 476805 1 1
2024-08-08 4 FORM 4 0001600620-24-000093 5199
2024-08-01 10-Q 10-Q 0001600620-24-000091 001-36421 241163981 34 6152428 1 1
2024-08-01 8-K 8-K 2.02,9.01 0001600620-24-000089 001-36421 241163954 34 374117 1 1
2024-06-14 8-K 8-K 5.07,9.01 0001600620-24-000087 001-36421 241046086 34 177982 1 1
2024-06-04 DEFA14A DEFA14A 0001600620-24-000085 001-36421 241019572 34 1424466
2024-06-04 DEFA14A DEFA14A 0001600620-24-000083 001-36421 241015412 34 5782046
2024-05-22 4 FORM 4 0001600620-24-000078 4645
2024-05-22 4 FORM 4 0001600620-24-000076 4623
2024-05-22 4 FORM 4 0001600620-24-000074 4633
2024-05-22 4 FORM 4 0001600620-24-000072 4619
2024-05-22 4 FORM 4 0001600620-24-000070 4645
2024-05-03 ARS ARS 0001600620-24-000068 001-36421 24913308 34 25831600
2024-05-03 DEFA14A DEFA14A 0001600620-24-000066 001-36421 24913181 34 444050
2024-05-03 DEF 14A DEF 14A 0001600620-24-000064 001-36421 24913108 34 4652302 1 1
2024-05-02 10-Q 10-Q 0001600620-24-000051 001-36421 24905056 34 5947415 1 1
2024-05-02 8-K 8-K 2.03,9.01 0001600620-24-000049 001-36421 24905044 34 343586 1 1
2024-04-29 10-K/A 10-K/A 0001600620-24-000041 001-36421 24890939 34 1437708 1 1
2024-03-20 SC 13D/A SC 13D/A 0001104659-24-036780 005-88628 24768658 34 150175
2024-03-07 4 FORM 4 0001600620-24-000038 5208
2024-03-07 4 FORM 4 0001600620-24-000037 5247
2024-03-07 4 FORM 4 0001600620-24-000036 5236
2024-03-07 4 FORM 4 0001600620-24-000035 5194
2024-03-07 4 FORM 4 0001600620-24-000034 5225
2024-02-29 4 FORM 4 0001600620-24-000028 4459
2024-02-29 8-K 8-K 5.02 0001600620-24-000027 001-36421 24703683 34 151409 1 1
2024-02-22 4 FORM 4 0001600620-24-000022 5047
2024-02-22 4 FORM 4 0001600620-24-000021 6328
2024-02-22 4 FORM 4 0001600620-24-000020 5091
2024-02-22 4 FORM 4 0001600620-24-000019 5080
2024-02-22 4 FORM 4 0001600620-24-000018 5102
2024-02-22 4 FORM 4 0001600620-24-000017 5062
2024-02-22 4/A FORM 4/A 0001600620-24-000015 4929
2024-02-22 4/A FORM 4/A 0001600620-24-000014 4951
2024-02-22 4/A FORM 4/A 0001600620-24-000013 4910
2024-02-15 10-K 10-K 0001600620-24-000012 001-36421 24641968 34 12193048 1 1
2024-02-15 8-K 8-K 2.02,2.05,8.01,9.01 0001600620-24-000010 001-36421 24641950 34 337531 1 1
2024-02-14 SC 13G armistice-auph123123.htm 0001172661-24-001321 005-88628 24636802 34 90486
2024-02-12 SC 13G/A ca05156v1022_021224.txt 0001086364-24-006951 005-88628 24617747 34 13577
2024-01-05 8-K 8-K 2.02,9.01 0001600620-24-000001 001-36421 24514362 34 185108 1 1
2023-11-02 10-Q 10-Q 0001600620-23-000044 001-36421 231369835 34 6164022 1 1
2023-11-02 8-K 8-K 2.02,9.01 0001600620-23-000043 001-36421 231369802 34 314937 1 1
2023-09-22 4 FORM 4 0001600620-23-000042 7448
2023-09-22 3 FORM 3 0001600620-23-000041 2973
2023-09-21 8-K 8-K 1.01,5.02,7.01,9.01 0001600620-23-000040 001-36421 231269182 34 340758 1 1
2023-08-21 4 FORM 4 0001600620-23-000038 7420
2023-08-21 3 FORM 3 0001600620-23-000036 2982
2023-08-21 4 FORM 4 0001600620-23-000034 7396
2023-08-21 3 FORM 3 0001600620-23-000032 2966
2023-08-21 8-K 8-K 5.02,9.01 0001600620-23-000030 001-36421 231189229 34 184431 1 1
2023-08-03 10-Q 10-Q 0001600620-23-000029 001-36421 231137871 34 5898117 1 1
2023-08-03 8-K 8-K 2.02,9.01 0001600620-23-000028 001-36421 231137853 34 309494 1 1
2023-07-06 PX14A6G px14a6g13781002_07052023.htm 0000921895-23-001658 001-36421 231072175 34 11259
2023-07-03 8-K 8-K 5.02,8.01,9.01 0001600620-23-000027 001-36421 231063500 34 174131 1 1
2023-06-01 PX14A6G px14a6g13781002_06012023.htm 0000921895-23-001401 001-36421 23984116 34 12121
2023-05-26 S-8 S-8 0001600620-23-000026 333-272244 23969720 33 594646
2023-05-23 4 FORM 4 0001600620-23-000024 10252
2023-05-23 4 FORM 4 0001600620-23-000022 11563
2023-05-23 4 FORM 4 0001600620-23-000021 8053
2023-05-23 4 FORM 4 0001600620-23-000020 11760
2023-05-23 4 FORM 4 0001600620-23-000019 6386
2023-05-23 4 FORM 4 0001600620-23-000018 11782
2023-05-23 4 FORM 4 0001600620-23-000017 11756
2023-05-17 8-K 8-K 5.07,9.01 0001600620-23-000015 001-36421 23931592 34 196244 1 1
2023-05-17 PX14A6G px14a6g13781002_05172023.htm 0000921895-23-001245 001-36421 23931520 34 12121
2023-05-11 PX14A6G px14a6g13781002_05112023.htm 0000921895-23-001127 001-36421 23909767 34 12829
2023-05-10 SC 13D/A SC 13D/A 0001104659-23-058469 005-88628 23906961 34 150583
2023-05-08 DEFA14A DEFA14A 0001600620-23-000014 001-36421 23897674 34 277867
2023-05-05 PX14A6G px14a6g13781002_05052023.htm 0000921895-23-001055 001-36421 23892056 34 12646
2023-05-04 10-Q 10-Q 0001600620-23-000012 001-36421 23886246 34 5617441 1 1
2023-05-04 8-K 8-K 2.02,9.01 0001600620-23-000010 001-36421 23886228 34 299249 1 1
2023-05-03 PX14A6G px14a6g13781002_05032023.htm 0000921895-23-001018 001-36421 23883230 34 11534
2023-05-02 DEFA14A DEFA14A 0001600620-23-000008 001-36421 23879794 34 882497
2023-04-28 DEFA14A DEFA14A 0001600620-23-000006 001-36421 23865778 34 880755
2023-04-26 PX14A6G px14a6g13781002_04242023.htm 0000921895-23-000942 001-36421 23847395 34 41376
2023-04-18 DEF 14A DEF 14A 0001600620-23-000005 001-36421 23827147 34 5634750 1 1
2023-04-05 8-K 8-K 7.01,9.01 0001600620-23-000004 001-36421 23801234 34 2040791 1 1
2023-03-13 8-K 8-K 8.01 0001628280-23-007613 001-36421 23725548 34 168595 1 1
2023-03-06 4 FORM 4 0001628280-23-006533 4788
2023-03-06 4 FORM 4 0001628280-23-006532 5365
2023-03-06 4 FORM 4 0001628280-23-006531 7285
2023-03-06 4 FORM 4 0001628280-23-006530 7263
2023-03-06 4 FORM 4 0001628280-23-006529 5395
2023-03-06 4 FORM 4 0001628280-23-006528 5223
2023-03-06 4 FORM 4 0001628280-23-006527 5250
2023-03-06 4 FORM 4 0001628280-23-006526 7251
2023-02-28 10-K 10-K 0001628280-23-005341 001-36421 23678228 34 12110637 1 1
2023-02-28 8-K 8-K 2.02 0001628280-23-005333 001-36421 23678194 34 316255 1 1
2023-02-14 SC 13G/A deeptrack-auph123122a1.htm 0001172661-23-000822 005-88628 23622845 34 103208
2023-02-07 SC 13G ca05156v1022_020723.txt 0001306550-23-007913 005-88628 23593823 34 13366
2023-01-27 8-K 8-K 8.01 0001628280-23-001666 001-36421 23562835 34 171377 1 1
2023-01-20 SC 13D/A SC 13D/A 0001104659-23-005429 005-88628 23541408 34 160765
2023-01-09 8-K 8-K 2.02 0001628280-23-000762 001-36421 23518201 34 199946 1 1
2023-01-06 SC 13D/A SC 13D/A 0001104659-23-001869 005-88628 23515439 34 117888
2023-01-03 8-K 8-K 8.01 0001628280-23-000097 001-36421 23502656 34 170568 1 1
2022-11-23 4 FORM 4 0001628280-22-030745 4676
2022-11-14 4 FORM 4 0001628280-22-029866 4414
2022-11-09 4 FORM 4 0001628280-22-029215 4919
2022-11-03 10-Q 10-Q 0001628280-22-027931 001-36421 221355999 34 6517192 1 1
2022-11-03 8-K 8-K 2.02 0001628280-22-027930 001-36421 221355977 34 320967 1 1
2022-10-28 SC 13G deeptrack-auph101822.htm 0001172661-22-002260 005-88628 221341961 34 103190
2022-10-21 8-K 8-K 5.02 0001628280-22-026779 001-36421 221322152 34 172115 1 1
2022-09-19 8-K 8-K 5.02,7.01,9.01 0001628280-22-025148 001-36421 221251098 34 175773 1 1
2022-08-04 10-Q 10-Q 0001628280-22-020820 001-36421 221134501 34 7250779 1 1
2022-08-04 8-K 8-K 2.02 0001628280-22-020811 001-36421 221134469 34 315144 1 1
2022-08-01 4 FORM 4 0001628280-22-019950 7550
2022-08-01 4 FORM 4 0001628280-22-019949 7527
2022-07-19 3 FORM 3 0001628280-22-019118 3060
2022-07-19 3 FORM 3 0001628280-22-019117 3039
2022-07-15 8-K 8-K 5.02 0001628280-22-018937 001-36421 221084233 34 171077 1 1
2022-07-11 4/A FORM 4/A 0001628280-22-018767 7066
2022-05-20 4 FORM 4 0001628280-22-015035 7320
2022-05-20 4 FORM 4 0001628280-22-015034 7433
2022-05-20 4 FORM 4 0001628280-22-015033 7411
2022-05-20 4 FORM 4 0001628280-22-015032 7436
2022-05-20 4 FORM 4 0001628280-22-015031 7421
2022-05-20 4 FORM 4 0001628280-22-015030 7407
2022-05-20 4 FORM 4 0001628280-22-015029 7435
2022-05-20 4 FORM 4 0001628280-22-015028 7419
2022-05-20 8-K 8-K 5.07 0001628280-22-015026 001-36421 22947593 34 193338 1 1
2022-05-10 10-Q 10-Q 0001628280-22-013439 001-36421 22907225 34 5281265 1 1
2022-05-10 8-K 8-K 2.02 0001628280-22-013437 001-36421 22907212 34 296304 1 1
2022-04-18 DEFA14A DEFA14A 0001628280-22-009440 001-36421 22831027 34 884171
2022-04-18 DEF 14A DEF 14A 0001628280-22-009439 001-36421 22831022 34 2005247
2022-03-11 4 FORM 4 0001628280-22-005882 4410
2022-03-08 4 FORM 4 0001628280-22-005381 4788
2022-03-04 4 FORM 4 0001628280-22-005130 11048
2022-03-04 4 FORM 4 0001628280-22-005129 11268
2022-03-04 4 FORM 4 0001628280-22-005127 11273
2022-03-04 4 FORM 4 0001628280-22-005124 11042
2022-03-04 4 FORM 4 0001628280-22-005123 11236
2022-03-04 4 FORM 4 0001628280-22-005121 9673
2022-03-04 4 FORM 4 0001628280-22-005119 11029
2022-03-04 4 FORM 4 0001628280-22-005118 11048
2022-03-03 SC 13D/A SC 13D/A 0001104659-22-030015 005-88628 22708892 34 98283
2022-02-28 10-K 10-K 0001628280-22-004082 001-36421 22683784 34 10171935 1 1
2022-02-28 8-K 8-K 2.02 0001628280-22-004080 001-36421 22683765 34 319031 1 1
2022-02-14 SC 13G/A SC 13G/A 0001104659-22-021994 005-88628 22626825 34 196496
2022-01-07 8-K/A 8-K/A 7.01,9.01 0001628280-22-000527 001-36421 22518246 34 1250542 1 1
2022-01-04 4 FORM 4 0001628280-22-000182 10268
2021-12-15 4 FORM 4 0001628280-21-025130 4875
2021-12-09 8-K 8-K 7.01 0001628280-21-024728 001-36421 211480229 34 1250072 1 1
2021-11-19 S-3ASR S-3ASR 0001193125-21-335311 333-261242 211429161 33 1293916
2021-11-12 4 FORM 4 0001628280-21-023169 15902
2021-11-12 4 FORM 4 0001628280-21-023153 21517
2021-11-03 4 FORM 4 0001628280-21-021484 8849
2021-11-03 4 FORM 4 0001628280-21-021477 8906
2021-11-03 10-Q 10-Q 0001628280-21-021464 001-36421 211375476 34 6043171 1 1
2021-11-03 8-K 8-K 2.02 0001628280-21-021239 001-36421 211372815 34 320785 1 1
2021-10-26 4 FORM 4 0001628280-21-020527 8908
2021-09-22 4 FORM 4 0001628280-21-019051 14423
2021-09-22 4 FORM 4 0001628280-21-019048 23324
2021-09-17 8-K/A 8-K/A 5.07,9.01 0001628280-21-018843 001-36421 211260396 34 175989 1 1
2021-09-16 4 FORM 4 0001628280-21-018782 11157
2021-09-14 4 FORM 4 0001628280-21-018603 18362
2021-09-14 4 FORM 4 0001628280-21-018595 7434
2021-09-14 4 FORM 4 0001628280-21-018594 9017
2021-09-08 4 FORM 4 0001628280-21-018219 4646
2021-09-08 4 FORM 4 0001628280-21-018218 5135
2021-08-27 4 FORM 4 0001628280-21-017720 5134
2021-08-26 4 FORM 4 0001628280-21-017662 4627
2021-08-17 8-K 8-K 1.01,9.01 0001628280-21-017175 001-36421 211182837 34 935270 1 1
2021-08-10 4 FORM 4 0001628280-21-016407 5125
2021-08-10 4 FORM 4 0001628280-21-016403 5136
2021-08-05 10-Q 10-Q 0001628280-21-015863 001-36421 211148387 34 5890605 1 1
2021-08-05 8-K 8-K 2.02,9.01 0001628280-21-015854 001-36421 211148284 34 318665 1 1
2021-07-29 4 FORM 4 0001628280-21-014882 5233
2021-07-19 8-K 8-K 8.01 0001628280-21-013970 001-36421 211096519 34 198358 1 1
2021-06-25 S-8 S-8 0001628280-21-012947 333-257424 211048352 33 464167
2021-06-25 8-K 8-K 7.01,9.01 0001628280-21-012936 001-36421 211047831 34 212892 1 1
2021-06-23 4 FORM 4 0001628280-21-012730 4841
2021-06-17 4 FORM 4 0001628280-21-012469 5186
2021-06-17 3 FORM 3 0001628280-21-012468 3036
2021-06-17 8-K 8-K 5.02 0001628280-21-012467 001-36421 211025204 34 200613 1 1
2021-06-16 4 FORM 4 0001628280-21-012389 5169
2021-06-16 4 FORM 4 0001628280-21-012388 5187
2021-06-16 4 FORM 4 0001628280-21-012387 5162
2021-06-16 4 FORM 4 0001628280-21-012386 5085
2021-06-16 4 FORM 4 0001628280-21-012385 5172
2021-06-16 4 FORM 4 0001628280-21-012384 5184
2021-06-16 4 FORM 4 0001628280-21-012383 5158
2021-06-10 8-K 8-K 5.02,5.07 0001628280-21-012006 001-36421 211008134 34 473695 1 1
2021-05-13 4 FORM 4 0001628280-21-010163 8494
2021-05-12 4 FORM 4 0001628280-21-010023 4440
2021-05-12 4 FORM 4 0001628280-21-010022 6748
2021-05-12 4 FORM 4 0001628280-21-010021 6934
2021-05-12 4 FORM 4 0001628280-21-010018 4384
2021-05-11 4 FORM 4 0001628280-21-009847 6948
2021-05-11 4 FORM 4 0001628280-21-009835 4444
2021-05-10 DEF 14A DEF 14A 0001628280-21-009686 001-36421 21907186 34 2307548
2021-05-06 10-Q 10-Q 0001628280-21-009306 001-36421 21897923 34 5342645 1 1
2021-05-06 8-K 8-K 2.02,9.01 0001628280-21-009298 001-36421 21897776 34 302894 1 1
2021-04-30 10-K/A 10-K/A 0001628280-21-008458 001-36421 21878236 34 1155327 1 1
2021-04-27 PRE 14A PRE 14A 0001628280-21-007747 001-36421 21859447 34 2320136
2021-04-27 8-K 8-K 5.03 0001628280-21-007736 001-36421 21859143 34 453791 1 1
2021-03-15 4 FORM 4 0001628280-21-004740 8817
2021-03-11 SC 13D/A GROWTH EQUITY OPPORTUNITIES FUND III, LLC (AURINIA) - SCHEDULE 13DA1E 0001072613-21-000299 005-88628 21731654 34 113292
2021-03-09 4 FORM 4 0001628280-21-004265 4807
2021-02-24 S-8 S-8 0001628280-21-003075 333-253454 21673717 33 242983
2021-02-24 8-K 8-K 7.01,8.01,9.01 0001628280-21-003067 001-36421 21673297 34 1351058 1 1
2021-02-24 10-K 10-K 0001628280-21-003060 001-36421 21673167 34 21170178 1 1
2021-02-17 SC 13G/A CONSONANCE CAPITAL MANAGEMENT LP 0001085146-21-001025 005-88628 21643994 34 55100
2021-02-16 SC 13G/A CONSONANCE CAPITAL MANAGEMENT LP 0001085146-21-000915 005-88628 21636196 34 55199
2021-02-12 SC 13G/A SC 13G/A 0001104659-21-021916 005-88628 21627349 34 181990
2021-02-08 SC 13G/A filing.txt 0000315066-21-000820 005-88628 21599351 34 8498
2021-02-02 4 FORM 4 0001628280-21-001281 6996
2021-02-02 4 FORM 4 0001628280-21-001279 13789
2021-01-29 4 FORM 4 0001628280-21-001096 4412
2021-01-27 SC 13D/A SC 13D/A 0001104659-21-008171 005-88628 21559883 34 119239
2021-01-26 SC 13D/A SC 13D/A 0001104659-21-007635 005-88628 21554099 34 74594
2021-01-25 8-K 8-K 9.01 0001628280-21-000758 001-36421 21548040 34 5430767 1 1
2021-01-04 3 FORM 3 SUBMISSION 0001209191-21-000497 8487
2021-01-04 3 FORM 3 SUBMISSION 0001209191-21-000496 14008
2021-01-04 3 FORM 3 SUBMISSION 0001209191-21-000495 8983
2021-01-04 3 FORM 3 SUBMISSION 0001209191-21-000494 13335
2021-01-04 3 FORM 3 SUBMISSION 0001209191-21-000493 9842
2021-01-04 3 FORM 3 SUBMISSION 0001209191-21-000490 14041
2021-01-04 3 FORM 3 SUBMISSION 0001209191-21-000487 9300
2021-01-04 3 FORM 3 SUBMISSION 0001209191-21-000486 9254
2021-01-04 3 FORM 3 SUBMISSION 0001209191-21-000482 13428
2021-01-04 3 FORM 3 SUBMISSION 0001209191-21-000462 15281
2021-01-04 3 FORM 3 SUBMISSION 0001209191-21-000459 10792
2021-01-04 3 FORM 3 SUBMISSION 0001209191-21-000457 11341
2021-01-04 3 FORM 3 SUBMISSION 0001209191-21-000453 10453
2021-01-04 3 FORM 3 SUBMISSION 0001209191-21-000442 9810
2021-01-04 3 FORM 3 SUBMISSION 0001209191-21-000440 9226
2021-01-04 3 FORM 3 SUBMISSION 0001209191-21-000437 10301
2020-12-30 6-K 6-K 0001628280-20-017844 001-36421 201426852 34 958220
2020-12-21 6-K AURINIA PHARMACEUTICALS INC. 6-K 0001157523-20-001616 001-36421 201404403 34 27081
2020-12-16 6-K AURINIA PHARMACEUTICALS INC. 6-K 0001157523-20-001599 001-36421 201390873 34 28056
2020-11-20 6-K AURINIA PHARMACEUTICALS INC. 6-K 0001157523-20-001537 001-36421 201333274 34 16892
2020-11-10 6-K 6-K 0001628280-20-016190 001-36421 201301097 34 1398313
2020-11-10 6-K AURINIA PHARMACEUTICALS INC. 6-K 0001157523-20-001479 001-36421 201301073 34 97980
2020-11-09 6-K AURINIA PHARMACEUTICALS INC. 6-K 0001157523-20-001474 001-36421 201297679 34 20999
2020-11-02 6-K AURINIA PHARMACEUTICALS INC. 6-K 0001157523-20-001411 001-36421 201280484 34 26310
2020-10-29 6-K AURINIA PHARMACEUTICALS INC. 6-K 0001157523-20-001378 001-36421 201270721 34 28891
2020-10-22 6-K AURINIA PHARMACEUTICALS INC. 6-K 0001157523-20-001337 001-36421 201255465 34 26888
2020-10-14 6-K AURINIA PHARMACEUTICALS INC. 6-K 0001157523-20-001306 001-36421 201238182 34 24666
2020-10-09 SC 13D/A SC 13D/A 0001104659-20-113903 005-88628 201233242 34 77005
2020-10-02 6-K AURINIA PHARMACEUTICALS INC. 6-K 0001157523-20-001285 001-36421 201220985 34 16395
2020-09-28 6-K AURINIA PHARMACEUTICALS INC. 6-K 0001157523-20-001271 001-36421 201201917 34 27984
2020-09-08 6-K AURINIA PHARMACEUTICALS INC. 6-K 0001157523-20-001232 001-36421 201162684 34 19196
2020-08-11 6-K 6-K 0001628280-20-012430 001-36421 201092421 34 1323602
2020-08-11 6-K AURINIA PHARMACEUTICALS INC. 6-K 0001157523-20-001168 001-36421 201092396 34 102079
2020-07-23 6-K 6-K 0001193125-20-197855 001-36421 201044238 34 268905
2020-07-23 SC 13D/A AMENDMENT 0001104659-20-086013 005-88628 201044103 34 132538
2020-07-23 SUPPL PROSPECTUS SUPPLEMENT NO. 2 0001193125-20-197784 333-238785 201043718 NE 1214502
2020-07-22 SUPPL PROSPECTUS SUPPLEMENT NO. 2 0001193125-20-197126 333-238785 201041726 NE 1215781
2020-07-22 6-K AURINIA PHARMACEUTICALS INC. 6-K 0001157523-20-001015 001-36421 201041669 34 20590
2020-07-21 6-K AURINIA PHARMACEUTICALS INC. 6-K 0001157523-20-001008 001-36421 201039606 34 30537
2020-06-26 SUPPL PROSPECTUS SUPPLEMENT NO. 1 0001193125-20-180928 333-238785 20994218 NE 1082509
2020-06-22 6-K AURINIA PHARMACEUTICALS INC. 6-K 0001157523-20-000921 001-36421 20977091 34 26235
2020-06-19 EFFECT xslEFFECTX01/primary_doc.xml F-10,,2020-06-19 16:00:00 9999999995-20-001488 333-238785 20977077 33 1698
2020-06-17 F-10/A AMENDMENT NO. 1 TO FORM F-10 0001193125-20-171378 333-238785 20970170 33 641550
2020-06-09 S-8 S-8 0001628280-20-009166 333-239048 20952587 33 951911
2020-06-09 6-K AURINIA PHARMACEUTICALS INC. 6-K 0001157523-20-000876 001-36421 20950821 34 28637
2020-06-05 6-K AURINIA PHARMACEUTICALS INC. 6-K 0001157523-20-000869 001-36421 20944651 34 28945
2020-06-03 6-K AURINIA PHARMACEUTICALS INC. 6-K 0001157523-20-000849 001-36421 20938866 34 41632
2020-05-29 F-X F-X 0001193125-20-155850 333-238785 20928366 33 18503
2020-05-29 F-10 FORM F-10 0001193125-20-155700 333-238785 20927717 33 641564
2020-05-26 6-K AURINIA PHARMACEUTICALS INC. 6-K 0001157523-20-000804 001-36421 20907985 34 27578
2020-05-14 6-K 6-K 0001628280-20-007783 001-36421 20877698 34 1367807
2020-05-14 6-K AURINIA PHARMACEUTICALS INC. 6-K 0001157523-20-000743 001-36421 20877667 34 92689
2020-04-28 6-K 6-K 0001628280-20-005759 001-36421 20825517 34 11960896
2020-04-27 6-K AURINIA PHARMACEUTICALS INC. 6-K 0001157523-20-000571 001-36421 20817099 34 23599
2020-04-20 6-K AURINIA PHARMACEUTICALS INC. 6-K 0001157523-20-000535 001-36421 20801505 34 23202
2020-03-19 6-K AURINIA PHARMACEUTICALS INC. 6-K 0001157523-20-000398 001-36421 20729314 34 28814
2020-03-17 6-K AURINIA PHARMACEUTICALS INC. 6-K 0001157523-20-000361 001-36421 20721861 34 22791
2020-03-16 6-K AURINIA PHARMACEUTICALS INC. 6-K 0001157523-20-000352 001-36421 20718227 34 20161
2020-03-12 6-K AURINIA PHARMACEUTICALS INC. 6-K 0001157523-20-000339 001-36421 20708760 34 19673
2020-03-05 40-F 40-F 0001628280-20-003036 001-36421 20690860 34 11212043 1
2020-03-05 6-K AURINIA PHARMACEUTICALS INC. 6-K 0001157523-20-000305 001-36421 20690784 34 130135
2020-02-25 6-K AURINIA PHARMACEUTICALS INC. 6-K 0001157523-20-000260 001-36421 20647194 34 31958
2020-02-14 SC 13G CONSONANCE CAPITAL MANAGEMENT LP 0001085146-20-000766 005-88628 20617330 34 58112
2020-02-13 SC 13G/A AMENDMENT NO. 1 TO SCHEDULE 13G 0001213900-20-003597 005-88628 20611092 34 83946
2020-02-07 SC 13G/A filing.txt 0000315066-20-000811 005-88628 20585430 34 8252
2020-01-27 SC 13G SCHEDULE 13G 0001104659-20-007143 005-88628 20549799 34 141750
2019-12-18 SC 13D/A SC 13D/A 0001104659-19-073834 005-88628 191292942 34 152677
2019-12-18 6-K 6-K 0001193125-19-316575 001-36421 191291195 34 23359
2019-12-12 6-K 6-K 0001193125-19-312201 001-36421 191281152 34 22466
2019-12-10 SC 13D/A SC 13D/A 0001104659-19-071472 005-88628 191278138 34 144557
2019-12-10 SUPPL PROSPECTUS SUPPLEMENT NO. 4 0001193125-19-310256 333-222413 191277982 NE 1073085
2019-12-10 6-K 6-K 0001193125-19-309672 001-36421 191276485 34 239462
2019-12-09 SUPPL PROSPECTUS SUPPLEMENT NO. 4 0001193125-19-308641 333-222413 191274275 NE 1072851
2019-12-09 6-K 6-K 0001193125-19-308631 001-36421 191274259 34 54370
2019-12-09 SC 13D/A SC 13D/A 0001104659-19-070762 005-88628 191274239 34 146313
2019-12-06 SC 13D/A SC 13D/A 0001104659-19-070670 005-88628 191273785 34 153501
2019-12-06 6-K AURINIA PHARMACEUTICALS INC. 6-K 0001157523-19-002335 001-36421 191272285 34 44992
2019-12-04 6-K AURINIA PHARMACEUTICALS INC. 6-K 0001157523-19-002316 001-36421 191266641 34 28032
2019-11-14 6-K 6-K 0001628280-19-014209 001-36421 191220000 34 1907353
2019-11-14 6-K AURINIA PHARMACEUTICALS INC. 6-K 0001157523-19-002270 001-36421 191219891 34 132271
2019-11-13 SC 13D/A SC 13D/A 0001104659-19-063369 005-88628 191214587 34 154844
2019-11-13 6-K AURINIA PHARMACEUTICALS INC. 6-K 0001157523-19-002261 001-36421 191213974 34 22755
2019-11-07 6-K AURINIA PHARMACEUTICALS INC. 6-K 0001157523-19-002221 001-36421 191198017 34 27206

Latest XBRL company facts

One latest value per concept from companyfacts (452 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 134.00M 2026-10-29 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
dei EntityPublicFloat Entity Public Float USD 1.00B 2025-06-30 2025 FY 10-K 2026-02-26 0001600620-26-000017
ecd CoSelectedMeasureAmt CoSelectedMeasureAmt USD 283.10M 2025-01-01 2025-12-31 DEF 14A 2026-04-21 0001600620-26-000039
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 5.14M 2025-01-01 2025-12-31 DEF 14A 2026-04-21 0001600620-26-000039
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 2.06M 2025-01-01 2025-12-31 DEF 14A 2026-04-21 0001600620-26-000039
ecd PeerGroupTotalShareholderRtnAmt PeerGroupTotalShareholderRtnAmt USD 83.61 2025-01-01 2025-12-31 DEF 14A 2026-04-21 0001600620-26-000039
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 17.55M 2025-01-01 2025-12-31 DEF 14A 2026-04-21 0001600620-26-000039
ecd PeoTotalCompAmt PeoTotalCompAmt USD 5.86M 2025-01-01 2025-12-31 DEF 14A 2026-04-21 0001600620-26-000039
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 115.33 2025-01-01 2025-12-31 DEF 14A 2026-04-21 0001600620-26-000039
ffd NetFeeAmt NetFeeAmt USD 7,597.48 2026-04-13 SC TO-T 2026-04-13 0001140361-26-014344
ffd TtlFeeAmt TtlFeeAmt USD 7,597.48 2026-04-13 SC TO-T 2026-04-13 0001140361-26-014344
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-04-13 SC TO-T 2026-04-13 0001140361-26-014344
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-04-13 SC TO-T 2026-04-13 0001140361-26-014344
ffd TtlTxValtn TtlTxValtn USD 55.01M 2026-04-13 SC TO-T 2026-04-13 0001140361-26-014344
ifrs-full AccrualsClassifiedAsCurrent AccrualsClassifiedAsCurrent USD 3.28M 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full AccumulatedOtherComprehensiveIncome AccumulatedOtherComprehensiveIncome USD -805,000 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill USD 17,000 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment USD 512,000 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full AdditionsToRightofuseAssets AdditionsToRightofuseAssets USD 425,000 2019-01-15 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full AdjustmentsForDecreaseIncreaseInTradeAccountReceivable AdjustmentsForDecreaseIncreaseInTradeAccountReceivable USD -151,000 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full AdjustmentsForDepreciationExpense AdjustmentsForDepreciationExpense USD 159,000 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full AdjustmentsForFairValueGainsLosses AdjustmentsForFairValueGainsLosses USD 5,000 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives USD -41.12M 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full AdjustmentsForIncreaseDecreaseInDeferredIncome AdjustmentsForIncreaseDecreaseInDeferredIncome USD -118,000 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full AdjustmentsForIncreaseDecreaseInTradeAccountPayable AdjustmentsForIncreaseDecreaseInTradeAccountPayable USD 4.11M 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full AdjustmentsForInterestExpense AdjustmentsForInterestExpense USD 39,000 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full AdjustmentsForReconcileProfitLoss AdjustmentsForReconcileProfitLoss USD -65.48M 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full AdjustmentsForSharebasedPayments AdjustmentsForSharebasedPayments USD 7.41M 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full AmortisationIntangibleAssetsOtherThanGoodwill AmortisationIntangibleAssetsOtherThanGoodwill USD 1.39M 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full Assets Assets USD 326.68M 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full BasicAndDilutedEarningsLossPerShare BasicAndDilutedEarningsLossPerShare USD/shares -1.33 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full CapitalCommitments CapitalCommitments USD 8.26M 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full CapitalReserve CapitalReserve USD 23.66M 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full CashAndCashEquivalents CashAndCashEquivalents USD 306.02M 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full CashFlowsFromUsedInFinancingActivities CashFlowsFromUsedInFinancingActivities USD 243.73M 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full CashFlowsFromUsedInInvestingActivities CashFlowsFromUsedInInvestingActivities USD 7.78M 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full CashFlowsFromUsedInOperatingActivities CashFlowsFromUsedInOperatingActivities USD -63.46M 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full CashOutflowForLeases CashOutflowForLeases USD 127,000 2019-01-16 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full ClosingForeignExchangeRate ClosingForeignExchangeRate CAD/USD 0.77 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full ComprehensiveIncome ComprehensiveIncome USD -64.12M 2018-01-01 2018-12-31 2018 FY 40-F 2019-03-19 0001628280-19-003130
ifrs-full CostOfInventoriesRecognisedAsExpenseDuringPeriod CostOfInventoriesRecognisedAsExpenseDuringPeriod USD 6.62M 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full CurrentAssets CurrentAssets USD 315.14M 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full CurrentInvestments CurrentInvestments USD 0 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full CurrentLiabilities CurrentLiabilities USD 11.29M 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full CurrentPrepaymentsAndOtherCurrentAssets CurrentPrepaymentsAndOtherCurrentAssets USD 8.75M 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full CurrentTradeReceivables CurrentTradeReceivables USD 368,000 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full DeferredIncomeClassifiedAsCurrent DeferredIncomeClassifiedAsCurrent USD 118,000 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full DeferredIncomeClassifiedAsNoncurrent DeferredIncomeClassifiedAsNoncurrent USD 206,000 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full DeferredTaxAssets DeferredTaxAssets USD 65.33M 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences USD 721,000 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full DepreciationPropertyPlantAndEquipment DepreciationPropertyPlantAndEquipment USD 159,000 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full DepreciationRightofuseAssets DepreciationRightofuseAssets USD 124,000 2019-01-16 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full DescriptionOfExpectedVolatilityShareOptionsGranted DescriptionOfExpectedVolatilityShareOptionsGranted pure 0.52 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full DescriptionOfOptionLifeShareOptionsGranted DescriptionOfOptionLifeShareOptionsGranted pure 4 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full DescriptionOfRiskFreeInterestRateShareOptionsGranted DescriptionOfRiskFreeInterestRateShareOptionsGranted pure 0.016 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full DirectorsRemunerationExpense DirectorsRemunerationExpense USD 592,000 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full DisposalsPropertyPlantAndEquipment DisposalsPropertyPlantAndEquipment USD 1,000 2017-01-01 2017-12-31 2018 FY 40-F 2019-03-19 0001628280-19-003130
ifrs-full Equity Equity USD 273.52M 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full EquityAndLiabilities EquityAndLiabilities USD 326.68M 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full ExercisePriceShareOptionsGranted ExercisePriceShareOptionsGranted USD 6.14 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full ExpectedDividendAsPercentageShareOptionsGranted ExpectedDividendAsPercentageShareOptionsGranted pure 0 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full ExpenseFromSharebasedPaymentTransactionsWithEmployees ExpenseFromSharebasedPaymentTransactionsWithEmployees USD 7.41M 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed USD 67,000 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full ExpenseRelatingToVariableLeasePaymentsNotIncludedInMeasurementOfLeaseLiabilities ExpenseRelatingToVariableLeasePaymentsNotIncludedInMeasurementOfLeaseLiabilities USD 79,000 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full FinanceIncome FinanceIncome USD 2.23M 2018-01-01 2018-12-31 2018 FY 40-F 2019-03-19 0001628280-19-003130
ifrs-full FinanceIncomeCost FinanceIncomeCost USD -39,000 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full FinancialAssetsAtAmortisedCost FinancialAssetsAtAmortisedCost USD 8,000 2018-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full FinancialAssetsAtFairValue FinancialAssetsAtFairValue USD 8,000 2018-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full GainsLossesOnChangeInFairValueOfDerivatives GainsLossesOnChangeInFairValueOfDerivatives USD -41.12M 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full GainsLossesOnDisposalsOfInvestments GainsLossesOnDisposalsOfInvestments USD 0 2018-01-01 2018-12-31 2018 FY 40-F 2019-03-19 0001628280-19-003130
ifrs-full GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss USD 60,000 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full GainsLossesOnRemeasuringAvailableforsaleFinancialAssetsNetOfTax GainsLossesOnRemeasuringAvailableforsaleFinancialAssetsNetOfTax USD -78,000 2017-01-01 2017-12-31 2017 FY 40-F 2018-03-15 0001628280-18-003228
ifrs-full GainsOnDisposalsOfPropertyPlantAndEquipment GainsOnDisposalsOfPropertyPlantAndEquipment USD 0 2018-01-01 2018-12-31 2018 FY 40-F 2019-03-19 0001628280-19-003130
ifrs-full GeneralAndAdministrativeExpense GeneralAndAdministrativeExpense USD 22.15M 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full IncomeTaxExpenseContinuingOperations IncomeTaxExpenseContinuingOperations USD 144,000 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full IncreaseDecreaseInAccountingEstimate IncreaseDecreaseInAccountingEstimate USD 78,000 2018-01-01 2018-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full IncreaseDecreaseInCashAndCashEquivalents IncreaseDecreaseInCashAndCashEquivalents USD 188.05M 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full IncreaseDecreaseInWorkingCapital IncreaseDecreaseInWorkingCapital USD -2.13M 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full IncreaseDecreaseThroughExerciseOfOptions IncreaseDecreaseThroughExerciseOfOptions USD 13.75M 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full IncreaseDecreaseThroughExerciseOfWarrantsEquity IncreaseDecreaseThroughExerciseOfWarrantsEquity USD 40.51M 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full IncreaseDecreaseThroughSharebasedPaymentTransactions IncreaseDecreaseThroughSharebasedPaymentTransactions USD 7.41M 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment USD -301,000 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full IntangibleAssetsOtherThanGoodwill IntangibleAssetsOtherThanGoodwill USD 11.24M 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full InterestExpense InterestExpense USD 39,000 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full InterestExpenseOnLeaseLiabilities InterestExpenseOnLeaseLiabilities USD 39,000 2019-01-16 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full InterestReceivedClassifiedAsOperatingActivities InterestReceivedClassifiedAsOperatingActivities USD 2.62M 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full IssuedCapital IssuedCapital USD 790.47M 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full IssueOfEquity IssueOfEquity USD 236.75M 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full KeyManagementPersonnelCompensation KeyManagementPersonnelCompensation USD 9.55M 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full KeyManagementPersonnelCompensationSharebasedPayment KeyManagementPersonnelCompensationSharebasedPayment USD 4.72M 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full KeyManagementPersonnelCompensationShorttermEmployeeBenefits KeyManagementPersonnelCompensationShorttermEmployeeBenefits USD 2.58M 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full KeyManagementPersonnelCompensationTerminationBenefits KeyManagementPersonnelCompensationTerminationBenefits USD 0 2018-01-01 2018-12-31 2018 FY 40-F 2019-03-19 0001628280-19-003130
ifrs-full LeaseAndSubleasePaymentsRecognisedAsExpense LeaseAndSubleasePaymentsRecognisedAsExpense USD 168,000 2018-01-01 2018-12-31 2018 FY 40-F 2019-03-19 0001628280-19-003130
ifrs-full LeaseLiabilities LeaseLiabilities USD 0 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full Liabilities Liabilities USD 53.17M 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full LicenceFeeIncome LicenceFeeIncome USD 318,000 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full LongtermDeposits LongtermDeposits USD 209,000 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full MinimumLeasePaymentsPayableUnderNoncancellableOperatingLease MinimumLeasePaymentsPayableUnderNoncancellableOperatingLease USD 800,000 2018-12-31 2018 FY 40-F 2019-03-19 0001628280-19-003130
ifrs-full NetDeferredTaxAssets NetDeferredTaxAssets USD 0 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full NoncurrentDerivativeFinancialLiabilities NoncurrentDerivativeFinancialLiabilities USD 29.35M 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full NumberOfOutstandingShareOptions NumberOfOutstandingShareOptions shares 7.82M 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full NumberOfShareOptionsExercisableInSharebasedPaymentArrangement NumberOfShareOptionsExercisableInSharebasedPaymentArrangement shares 3.42M 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full NumberOfShareOptionsExercisedInSharebasedPaymentArrangement NumberOfShareOptionsExercisedInSharebasedPaymentArrangement shares 3.58M 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full NumberOfShareOptionsExpiredInSharebasedPaymentArrangement NumberOfShareOptionsExpiredInSharebasedPaymentArrangement shares 0 2017-01-01 2017-12-31 2017 FY 40-F 2018-03-15 0001628280-18-003228
ifrs-full NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement shares 309,000 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full NumberOfShareOptionsGrantedInSharebasedPaymentArrangement NumberOfShareOptionsGrantedInSharebasedPaymentArrangement shares 2.52M 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full OperatingExpense OperatingExpense USD 85.56M 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full OtherComprehensiveIncomeNetOfTaxAvailableforsaleFinancialAssets OtherComprehensiveIncomeNetOfTaxAvailableforsaleFinancialAssets USD 0 2018-01-01 2018-12-31 2018 FY 40-F 2019-03-19 0001628280-19-003130
ifrs-full OtherOperatingIncomeExpense OtherOperatingIncomeExpense USD -8.99M 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities USD -127,000 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full ProceedsFromExerciseOfOptions ProceedsFromExerciseOfOptions USD 13.75M 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full ProceedsFromIssueOfOrdinaryShares ProceedsFromIssueOfOrdinaryShares USD 0 2018-01-01 2018-12-31 2018 FY 40-F 2019-03-19 0001628280-19-003130
ifrs-full ProceedsFromIssuingOtherEquityInstruments ProceedsFromIssuingOtherEquityInstruments USD 0 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities USD 0 2017-01-01 2017-12-31 2017 FY 40-F 2018-03-15 0001628280-18-003228
ifrs-full ProceedsFromSalesOrMaturityOfFinancialInstrumentsClassifiedAsInvestingActivities ProceedsFromSalesOrMaturityOfFinancialInstrumentsClassifiedAsInvestingActivities USD 7.88M 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full ProfessionalFeesExpense ProfessionalFeesExpense USD 4.72M 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full ProfitLoss ProfitLoss USD -123.85M 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full ProfitLossBeforeTax ProfitLossBeforeTax USD -123.70M 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full ProfitLossFromOperatingActivities ProfitLossFromOperatingActivities USD -85.24M 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full PropertyPlantAndEquipment PropertyPlantAndEquipment USD 93,000 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities USD 0 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities USD 17,000 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities USD 87,000 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full ResearchAndDevelopmentExpense ResearchAndDevelopmentExpense USD 52.87M 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full RetainedEarnings RetainedEarnings USD -539.81M 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full Revenue Revenue USD 318,000 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full RevenueFromContractsWithCustomers RevenueFromContractsWithCustomers USD 2,000 2017-01-01 2017-12-31 2017 FY 40-F 2018-03-15 0001628280-18-003228
ifrs-full RevenueFromInterest RevenueFromInterest USD 2.70M 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full RightofuseAssets RightofuseAssets USD 0 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full ServicesExpense ServicesExpense USD 1,000 2017-01-01 2017-12-31 2017 FY 40-F 2018-03-15 0001628280-18-003228
ifrs-full ShareIssueRelatedCost ShareIssueRelatedCost USD 13.63M 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full ShorttermEmployeeBenefitsAccruals ShorttermEmployeeBenefitsAccruals USD 3.74M 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full TaxEffectFromChangeInTaxRate TaxEffectFromChangeInTaxRate USD 2.96M 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss USD 2.18M 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full TaxEffectOfForeignTaxRates TaxEffectOfForeignTaxRates USD 144,000 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full TaxExpenseIncomeAtApplicableTaxRate TaxExpenseIncomeAtApplicableTaxRate USD -31.47M 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full TradeAndOtherCurrentPayables TradeAndOtherCurrentPayables USD 11.18M 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full TradeAndOtherCurrentPayablesToTradeSuppliers TradeAndOtherCurrentPayablesToTradeSuppliers USD 4.15M 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement CAD 6.1 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement CAD 5.09 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement CAD 0 2017-01-01 2017-12-31 2017 FY 40-F 2018-03-15 0001628280-18-003228
ifrs-full WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement CAD 6.88 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement CAD 8.14 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement CAD 7.04 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16 WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16 pure 0.1 2019-01-15 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full WeightedAverageRemainingContractualLifeOfOutstandingShareOptions WeightedAverageRemainingContractualLifeOfOutstandingShareOptions Y 7.86 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
ifrs-full WeightedAverageShares WeightedAverageShares shares 93.02M 2019-01-01 2019-12-31 2019 FY 40-F 2020-03-05 0001628280-20-003036
srt StockRepurchaseProgramAuthorizedAmount1 StockRepurchaseProgramAuthorizedAmount1 USD 150.00M 2024-02-15 2025 Q1 10-Q 2025-05-12 0001600620-25-000049
us-gaap AccountsAndOtherReceivablesNetCurrent Accounts and Other Receivables, Net, Current USD 47.41M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 63.30M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 3.01M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap AccountsPayableTradeCurrent Accounts Payable, Trade, Current USD 8.88M 2024-09-30 2024 Q3 10-Q 2024-11-07 0001600620-24-000108
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 6.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap AccruedIncomeTaxes Accrued Income Taxes USD 1.03M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 63.30M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap AccruedMarketingCostsCurrent Accrued Marketing Costs, Current USD 1.99M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 3.53M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -1.13M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 77.04M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation Share-based Payment Arrangement, Decrease for Tax Withholding Obligation USD 14,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 6.12M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 12.27M 2020-01-01 2020-09-30 2021 Q3 10-Q 2021-11-03 0001628280-21-021464
us-gaap AdvertisingExpense Advertising Expense USD 15.40M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-15 0001600620-24-000012
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 8.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 0 2024-09-30 2024 Q3 10-Q 2024-11-07 0001600620-24-000108
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 400,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-06 0001600620-26-000062
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 2.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap Assets Assets USD 825.70M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap AssetsCurrent Assets, Current USD 587.89M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 486.88M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap AvailableForSaleDebtSecuritiesGrossUnrealizedGain Debt Securities, Available-for-sale, Unrealized Gain USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap AvailableForSaleDebtSecuritiesGrossUnrealizedLoss Debt Securities, Available-for-sale, Unrealized Loss USD 499,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 311.60M 2024-09-30 2024 Q3 10-Q 2024-11-07 0001600620-24-000108
us-gaap CapitalLeaseObligationsIncurred Lease Obligation Incurred USD 531,000 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-03 0001600620-23-000029
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 45.79M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 46.15M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -34.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-06-30 2026 Q2 10-Q 2026-08-06 0001600620-26-000062
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 134.00M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 134.00M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap CommonStockValueOutstanding Common Stock, Value, Outstanding USD 1.13B 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD 102.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 10.41M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 12.65M 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap CostOfRevenue Cost of Revenue USD 21.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap CostsAndExpenses Costs and Expenses USD 121.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-15 0001600620-24-000012
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 3.13M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 3.15M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap DebtSecuritiesAvailableForSaleAllowanceForCreditLoss Debt Securities, Available-for-sale, Allowance for Credit Loss USD 487.38M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap DebtSecuritiesAvailableForSaleUnrealizedGainLoss Debt Securities, Available-for-sale, Unrealized Gain (Loss) USD 300,000 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0001600620-24-000108
us-gaap DebtSecuritiesCurrent Debt Securities, Current USD 440.74M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLossCurrent DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLossCurrent USD 0 2022-12-31 2022 FY 10-K 2023-02-28 0001628280-23-005341
us-gaap DebtSecuritiesNoncurrent Debt Securities, Noncurrent USD 0 2024-12-31 2024 FY 10-K 2025-02-27 0001600620-25-000011
us-gaap DeferredCreditsAndOtherLiabilitiesNoncurrent Deferred Credits and Other Liabilities, Noncurrent USD 23.10M 2026-05-11 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-15 0001600620-24-000012
us-gaap DeferredFederalStateAndLocalTaxExpenseBenefit Deferred Federal, State and Local, Tax Expense (Benefit) USD -114.14M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-15 0001600620-24-000012
us-gaap DeferredIncomeTaxAssetsNet Deferred Income Tax Assets, Net USD 170.65M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 28.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 19.01M 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap DeferredIncomeTaxLiabilitiesNet Deferred Income Tax Liabilities, Net USD 23.13M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 7.16M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD -62.05M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 100.88M 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 195.20M 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 0 2023-12-31 2023 FY 10-K 2024-02-15 0001600620-24-000012
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 176.19M 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 195.20M 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 47.62M 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 5.86M 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 8.89M 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits USD 1.93M 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 7.80M 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 4.05M 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 18.61M 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 400,000 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap DepositsAssetsCurrent Deposits Assets, Current USD 4.19M 2024-09-30 2024 Q3 10-Q 2024-11-07 0001600620-24-000108
us-gaap Depreciation Depreciation USD 600,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 14.49M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 6.00M 2020-12-31 2021 FY 10-K 2022-02-28 0001628280-22-004082
us-gaap DueToRelatedPartiesNoncurrent Due to Related Parties, Noncurrent USD 6.00M 2019-12-31 2020 FY 10-K 2021-02-24 0001628280-21-003060
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares 0.78 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.4 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-06 0001628280-21-009306
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares 0.76 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0.213 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.25 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -1.331 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure -0.065 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure -0.078 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0.008 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent pure 0.013 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-15 0001600620-24-000012
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure 1.063 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0.017 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure 0.02 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0.003 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsForeign Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.021 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 10.94M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 19.70M 2024-12-31 2024 FY 10-K 2025-02-27 0001600620-25-000011
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 31.90M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap FinanceLeaseInterestPaymentOnLiability Finance Lease, Interest Payment on Liability USD 3.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap FinanceLeaseLiability Finance Lease, Liability USD 55.18M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 16.15M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 39.03M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap FinanceLeaseLiabilityPaymentsDue Finance Lease, Liability, Payment, Due USD 60.88M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap FinanceLeaseLiabilityPaymentsDueAfterYearFive Finance Lease, Liability, to be Paid, after Year Five USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap FinanceLeaseLiabilityPaymentsDueNextTwelveMonths Finance Lease, Liability, to be Paid, Year One USD 17.39M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap FinanceLeaseLiabilityPaymentsDueYearFive Finance Lease, Liability, to be Paid, Year Five USD 4.57M 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap FinanceLeaseLiabilityPaymentsDueYearFour Finance Lease, Liability, to be Paid, Year Four USD 4.35M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap FinanceLeaseLiabilityPaymentsDueYearThree Finance Lease, Liability, to be Paid, Year Three USD 17.39M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap FinanceLeaseLiabilityPaymentsDueYearTwo Finance Lease, Liability, to be Paid, Year Two USD 17.39M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear Finance Lease, Liability, to be Paid, Remainder of Fiscal Year USD 4.35M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap FinanceLeaseLiabilityUndiscountedExcessAmount Finance Lease, Liability, Undiscounted Excess Amount USD 5.71M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 10.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap FinanceLeaseRightOfUseAsset Finance Lease, Right-of-Use Asset, after Accumulated Amortization USD 60.80M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap FinanceLeaseWeightedAverageDiscountRatePercent Finance Lease, Weighted Average Discount Rate, Percent pure 0.062 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 17.25M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 3.00M 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 3.00M 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 3.00M 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 3.00M 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 3.00M 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 20.42M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 3.17M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 70.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap HeldToMaturitySecurities Debt Securities, Held-to-maturity USD 330.53M 2024-06-30 2024 Q2 10-Q 2024-08-01 0001600620-24-000091
us-gaap HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain USD 0 2024-06-30 2024 Q2 10-Q 2024-08-01 0001600620-24-000091
us-gaap HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss USD 53,000 2024-06-30 2024 Q2 10-Q 2024-08-01 0001600620-24-000091
us-gaap HeldToMaturitySecuritiesFairValue Debt Securities, Held-to-maturity, Fair Value USD 330.48M 2024-06-30 2024 Q2 10-Q 2024-08-01 0001600620-24-000091
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD 103.91M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD 131.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 10.25M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap IncomeTaxesPaid Income Taxes Paid USD 496,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-15 0001600620-24-000012
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 2.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap IncomeTaxesReceivable Income Taxes Receivable, Current USD 481,000 2020-12-31 2020 FY 10-K 2021-02-24 0001628280-21-003060
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 27.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap IncomeTaxPaidStateAndLocalAfterRefundReceived IncomeTaxPaidStateAndLocalAfterRefundReceived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD -151.98M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD -481,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD -581,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD 28.54M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 945,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 7.91M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 1.97M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap IncomeTaxReconciliationOtherReconcilingItems Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount USD 152,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -298,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap IncomeTaxReconciliationTaxCreditsForeign Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Amount USD 4,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 153,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -2.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 934,000 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0001600620-24-000108
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD -4.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD 1.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD -1.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -670,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD 2.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap IncreaseDecreaseInReceivables Increase (Decrease) in Receivables USD 5.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap InterestExpense Interest Expense USD 2.48M 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-01 0001600620-24-000091
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 2.83M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD 8.71M 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-01 0001600620-24-000091
us-gaap InterestIncomeOther Interest Income, Other USD 529,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-28 0001628280-22-004082
us-gaap InterestReceivable Interest Receivable USD 1.20M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap InterestReceivableCurrent Interest Receivable, Current USD 486,000 2020-12-31 2020 FY 10-K 2021-02-24 0001628280-21-003060
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 0 2024-09-30 2024 Q3 10-Q 2024-11-07 0001600620-24-000108
us-gaap InventoryFinishedGoodsNetOfReserves Inventory, Finished Goods, Net of Reserves USD 1.34M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap InventoryNet Inventory, Net USD 43.73M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap InventoryRawMaterialsNetOfReserves Inventory, Raw Materials, Net of Reserves USD 658,000 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap InventoryValuationReserves Inventory Valuation Reserves USD 0 2025-09-30 2025 Q3 10-Q 2025-11-04 0001600620-25-000106
us-gaap InventoryWorkInProcess Inventory, Work in Process, Gross USD 13.79M 2021-06-30 2021 Q2 10-Q 2021-08-05 0001628280-21-015863
us-gaap InventoryWorkInProcessNetOfReserves Inventory, Work in Process, Net of Reserves USD 41.73M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap InventoryWriteDown Inventory Write-down USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 11.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap InvestmentsFairValueDisclosure Investments, Fair Value Disclosure USD 286.21M 2022-03-31 2022 Q1 10-Q 2022-05-10 0001628280-22-013439
us-gaap LeaseCost Lease, Cost USD 1.24M 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-28 0001628280-22-004082
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 3.72M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 839,000 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 2.59M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 1.24M 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 0 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 10,000 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 824,000 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 296,000 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 232,000 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap Liabilities Liabilities USD 168.19M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 825.70M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap LiabilitiesCurrent Liabilities, Current USD 96.00M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap LongTermPurchaseCommitmentAmount Long-term Purchase Commitment, Amount USD 25.40M 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-06 0001628280-21-009306
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD -53.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -112.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD 131.49M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD 103.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap NoncurrentAssets Long-Lived Assets USD 79.57M 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap NumberOfReportingUnits Number of Reporting Units reportingUnit 1 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-03 0001628280-21-021464
us-gaap NumberOfStores Number of Stores numberOfStore 2 2023-12-31 2023 FY 10-K 2024-02-15 0001600620-24-000012
us-gaap OperatingExpenses Operating Expenses USD 178.14M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap OperatingIncomeLoss Operating Income (Loss) USD 123.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap OperatingLeaseCost Operating Lease, Cost USD 800,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 3.48M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 1.81M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 1.68M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap OperatingLeasePayments Operating Lease, Payments USD 1.10M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 1.37M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-15 0001600620-24-000012
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.053 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 197.40M 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 6.48M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap OtherAssetsCurrent Other Assets, Current USD 3.95M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 93,000 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent USD -533,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD -155,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax USD 0 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0001600620-24-000108
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -209,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-28 0001628280-23-005341
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 1.32M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 1.19M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD 1.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap OtherOperatingIncomeExpenseNet Other Operating Income (Expense), Net USD 7.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 4.94M 2026-06-30 2026 Q2 10-Q 2026-08-06 0001600620-26-000062
us-gaap OtherReceivablesNetCurrent Other Receivables, Net, Current USD 51,000 2020-12-31 2020 FY 10-K 2021-02-24 0001628280-21-003060
us-gaap PaymentForContingentConsiderationLiabilityFinancingActivities Payment for Contingent Consideration Liability, Financing Activities USD 3.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap PaymentsForCapitalImprovements Payments for Capital Improvements CHF 21.00M 2021-01-01 2021-01-31 2023 Q1 10-Q 2023-05-04 0001600620-23-000012
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 74.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap PaymentsForRestructuring Payments for Restructuring USD 0 2024-07-01 2024-09-30 2025 Q3 10-Q 2025-11-04 0001600620-25-000106
us-gaap PaymentsForSoftware Payments for Software USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-15 0001600620-24-000012
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 33.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD -5.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 225,000 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0001600620-24-000108
us-gaap PaymentsToAcquireLeaseReceivables Payments to Acquire Lease Receivables USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 415.16M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap PaymentsToAcquireOtherInvestments Payments to Acquire Other Investments USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-15 0001600620-24-000012
us-gaap PaymentsToAcquireOtherProductiveAssets Payments to Acquire Other Productive Assets USD 63,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap PrepaidAdvertising Prepaid Advertising USD 5.32M 2021-12-31 2021 FY 10-K 2022-02-28 0001628280-22-004082
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 17.42M 2022-06-30 2022 Q2 10-Q 2022-08-04 0001628280-22-020820
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 7.84M 2024-06-30 2024 Q2 10-Q 2024-08-01 0001600620-24-000091
us-gaap PrepaidInsurance Prepaid Insurance USD 355,000 2026-03-31 2026 Q1 10-Q 2026-05-07 0001600620-26-000049
us-gaap ProceedsFromInterestReceived Proceeds from Interest Received USD 2.80M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0001600620-24-000108
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 363,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 573.14M 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-24 0001628280-21-003060
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 297.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 69.56M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-28 0001628280-23-005341
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 5.26M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 1.74M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap PurchaseObligation Purchase Obligation USD 2.30M 2020-12-31 2020 FY 10-K 2021-02-24 0001628280-21-003060
us-gaap PurchaseObligationDueInNextTwelveMonths Purchase Obligation, to be Paid, Year One USD 2.23M 2020-12-31 2020 FY 10-K 2021-02-24 0001628280-21-003060
us-gaap PurchaseObligationDueInSecondYear Purchase Obligation, to be Paid, Year Two USD 65,000 2020-12-31 2020 FY 10-K 2021-02-24 0001628280-21-003060
us-gaap PurchaseObligationDueInThirdYear Purchase Obligation, to be Paid, Year Three USD 0 2020-12-31 2020 FY 10-K 2021-02-24 0001628280-21-003060
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 37.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap RestrictedCash Restricted Cash USD 120,000 2023-12-31 2023 FY 10-K 2024-02-15 0001600620-24-000012
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 353,000 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent Restructuring and Related Cost, Number of Positions Eliminated, Period Percent pure 0.25 2024-02-01 2024-02-29 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap RestructuringCosts Restructuring Costs USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap RestructuringCostsAndAssetImpairmentCharges Restructuring Costs and Asset Impairment Charges USD 7.75M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0001600620-24-000108
us-gaap RestructuringReserve Restructuring Reserve USD 2.10M 2024-03-31 2024 Q1 10-Q 2024-05-02 0001600620-24-000051
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -545.90M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 244.62M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability Right-of-Use Asset Obtained in Exchange for Finance Lease Liability USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 117.62M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-03 0001600620-23-000029
us-gaap SaleOfStockConsiderationReceivedOnTransaction Sale of Stock, Consideration Received on Transaction USD 15.00M 2018-03-29 2021 FY 10-K 2022-02-28 0001628280-22-004082
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 195.00M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-15 0001600620-24-000012
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 8.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 417,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-15 0001600620-24-000012
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value USD/shares 9.33 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-15 0001600620-24-000012
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 6.83M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-15 0001600620-24-000012
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 9.03 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-15 0001600620-24-000012
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 7.81M 2023-12-31 2023 FY 10-K 2024-02-15 0001600620-24-000012
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 9.29 2023-12-31 2023 FY 10-K 2024-02-15 0001600620-24-000012
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 583,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-15 0001600620-24-000012
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 11.57 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-15 0001600620-24-000012
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.039 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate pure 0.68 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 16.00M 2021-03-31 2021 Q1 10-Q 2021-05-06 0001628280-21-009306
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 6.53M 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 10.87 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 1.40M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 1.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 11.5 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 3.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 8.77 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 54.07M 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 5.02M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 12.78 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 8.72M 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 10.08 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 4.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 9.54 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 14.67 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 27,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-28 0001628280-22-004082
us-gaap ShortTermLeasePayments Short-term Lease Payments USD 57,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-28 0001628280-23-005341
us-gaap StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants USD 365,000 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-15 0001600620-24-000012
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 657.52M 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 5.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 363,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 196.74M 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-15 0001600620-24-000012
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 4.98M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap StockRepurchasedAndRetiredDuringPeriodValue Stock Repurchased and Retired During Period, Value USD 38.11M 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap StockRepurchasedDuringPeriodShares Stock Repurchased During Period, Shares shares 5.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 74.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap StockRepurchaseProgramAuthorizedAmount1 Stock Repurchase Program, Authorized Amount USD 150.00M 2024-02-29 2024 Q1 10-Q 2024-05-02 0001600620-24-000051
us-gaap TangibleAssetImpairmentCharges Tangible Asset Impairment Charges USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap TaxesPayableCurrent Taxes Payable, Current USD 1.01M 2024-09-30 2024 Q3 10-Q 2024-11-07 0001600620-24-000108
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD -154.40M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001600620-26-000017
us-gaap VariableLeaseCost Variable Lease, Cost USD 167,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-28 0001628280-22-004082
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 3.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 135.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 129.37M 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-28 0001628280-22-004082
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 131.97M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-30 0001600620-26-000075

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →